# DataMeds AI, Inc. (MEDS)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/datameds-ai-inc/ JSON: https://steadybase.io/company/datameds-ai-inc.json Checked Nov 10, 2026. Latest filing read: Aug 17, 2026.

## Company

- Legal name: DataMeds AI, Inc.
- Ticker: MEDS (Nasdaq)
- SEC CIK: 0002030763
- Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Headquarters: Tampa, FL
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: wellgisticshealth.com
- Investor relations: https://datamedsai.com/investors/
- LinkedIn: https://www.linkedin.com/company/wellgisticshealth
- Next earnings date: Nov 18, 2026

## Key facts

- Revenue: $23.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/0001493152-26-012004-index.html
- Operating income: -$93.7M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/0001493152-26-012004-index.html
- Net income: -$101.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/0001493152-26-012004-index.html
- SG&A: $71.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/0001493152-26-012004-index.html
- Shares outstanding: 3,061,919 as of Aug 17, 2026 (10-Q filed Aug 17, 2026). Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226038581/0001493152-26-038581-index.html
- Auditor: Suri & Co., Chartered Accountants, Bengaluru, India, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/form10-k.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $23.3M | -$93.7M | -$101.3M | $71.6M |
| Dec 31, 2024 | $18.1M | -$6.1M | -$6.9M | $6.8M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/datameds-ai-inc.json

## Officers and directors

- Prashant Patel, Chief Executive Officer. Source: Form 4 filed Jun 25, 2026, https://www.sec.gov/Archives/edgar/data/2030763/000149315226030151/0001493152-26-030151-index.htm
- Eric Sherb, Chief Financial Officer (Principal Financial Officer). Source: 10-Q filed Aug 17, 2026, https://www.sec.gov/Archives/edgar/data/2030763/000149315226038581/ex31-2.htm
- Michael L. Peterson, Director. Source: 10-K filed Mar 20, 2026, https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/form10-k.htm

## Recent 8-K events

- Nov 5, 2026: Item 1.02, Termination of a material definitive agreement; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226050033/form8-k.htm
- Oct 26, 2026: Item 1.01, Entry into a material definitive agreement; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226048573/form8-k.htm
- Oct 20, 2026: Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226047711/form8-k.htm
- Oct 16, 2026: Item 1.01, Entry into a material definitive agreement; Item 3.01, Notice of delisting or failure to meet listing standards; Item 3.02, Unregistered sales of equity securities. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226047451/form8-k.htm
- Oct 13, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226046887/form8-k.htm
- Sep 17, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226043169/form8-k.htm
- Sep 16, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 3.02, Unregistered sales of equity securities; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226042951/form8-k.htm
- Aug 18, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226038891/form8-k.htm
- Aug 14, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226038475/form8-k.htm
- Aug 4, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226036005/form8-k.htm

## What management said

- "Having been in leadership now for just under three months, I am excited with the significant progress we are making towards the important milestone of launching the Health Lives Here app together with NFLAH" Gerald Commissiong, interim co-CEO of DataMEDS (8-K filed Aug 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/2030763/000149315226038891/ex99-1.htm

## Latest filings

- 8-K filed Oct 26, 2026: https://www.sec.gov/Archives/edgar/data/2030763/000149315226048573/form8-k.htm
- 10-K filed Mar 20, 2026: https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/form10-k.htm
- 10-Q filed Aug 17, 2026: https://www.sec.gov/Archives/edgar/data/2030763/000149315226038581/form10-q.htm
- DEF 14A filed May 4, 2026: https://www.sec.gov/Archives/edgar/data/2030763/000149315226021106/formdef14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/